TherapeuticsMD, Inc. Financial Ratios — TXMD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-979.78	-953.76	-83.66	-89.54	-128.12	-83.14	-53.85	-74.67	-73.71	-82	-98.22	86.17	-15.37	-5.31	-1.49
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-12.55	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.54	- -	- -	- -
Gross Margin (%)	54.64	64.69	77.67	75.56	77.63	78.38	84.28	83	87.24	75.37	45.51	98	100	100	100
EBITDA Margin (%)	-257.28	-421.48	-293.43	-359.3	-422.62	-465.59	-461.42	-807.02	-301.76	-233.5	-3,064.17	16.96	-583.79	-202.39	-99.97
Operating Margin (%)	-259.9	-422.95	-294.09	-359.65	-422.93	-466.27	-462.69	-808.85	-304.56	-239.77	-3,092.77	15.24	-654.61	-275.07	-139.44
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	133.91	15.24	- -	- -
Pretax Margin (%)	-618.4	-919.86	-323.84	-360.82	-422.37	-464.32	-458.5	-823.74	-354.79	-282.9	-3,082.2	1.54	-594.62	-133.05	-21.61
Profit Margin (%)	-618.4	-919.86	-323.84	-360.82	-422.37	-464.32	-458.5	-823.74	-354.79	-282.9	-6,700.93	160.08	-789.4	-123.85	-18.83
Net Income to Common Margin (%)	-618.4	-919.86	-323.84	-360.82	-422.37	-464.32	-458.5	-823.74	-354.79	-282.9	-6,700.93	160.08	-789.4	-123.85	-18.83
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	2	4	- -	- -	- -	- -	- -	73	205	249	198	9	8	7	6
ST Debt	2	- -	- -	- -	- -	- -	- -	- -	2	2	190	1	1	2	1
LT Debt	- -	4	- -	- -	- -	- -	- -	73	204	246	8	7	7	6	5
Total Debt/EBITDA	-0.44	-0.22	- -	- -	- -	- -	- -	-0.56	-1.37	-1.64	-2.51	0.74	-1.05	-2.01	-2.02
Net Debt/EBITDA	-0.41	-0.13	2.1	0.95	0.76	1.46	1.64	0.68	-0.23	-1.04	-1.56	-3.21	0.57	1.42	2.48
Total Debt/EBIT	-0.43	-0.22	- -	- -	- -	- -	- -	-0.56	-1.36	-1.6	-2.48	0.82	-0.94	-1.48	-1.45
Net Debt/EBIT	-0.41	-0.13	2.1	0.95	0.76	1.46	1.64	0.68	-0.22	-1.01	-1.55	-3.57	0.51	1.04	1.78
EBITDA to Interest Expense	-83.45	-8.45	-9.64	-207.63	- -	- -	- -	-27.77	-9.07	-5.81	-3.49	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-84.03	-8.59	-9.82	-210	- -	- -	- -	-32.33	-10.51	-5.88	-3.59	- -	- -	- -	- -
EBIT to Interest Expense	-84.3	-8.48	-9.67	-207.83	- -	- -	- -	-27.84	-9.15	-5.97	-3.53	- -	- -	- -	- -
Interest Expense	- -	2	3	- -	- -	- -	- -	5	17	26	23	- -	- -	- -	- -
Common Equity/Total Assets	-1,175.36	-877.74	-129.62	-227.82	-297.91	-217.24	-269.81	-244.85	-261.35	-483.81	-620.37	-1,038.44	-2,192.69	-2,451.73	-2,529.16
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	75.24	2,214.73	- -	- -	20.97	22.3	20.25	19.06
Long-Term Debt/Capital (%)	- -	-7.41	- -	- -	- -	- -	- -	-16.47	-41.6	-39.11	-0.94	-0.79	-0.69	-0.59	-0.54
Long-Term Debt/Total Assets (%)	- -	60.57	- -	- -	- -	- -	- -	34.62	76.61	135.66	4.76	8.15	15.08	14.28	13.6
Total Debt/Equity (%)	-137.28	-250.44	- -	- -	- -	- -	- -	75.24	2,231.05	-200.5	-211.16	24.92	27.33	26.21	22.69
Total Debt/Capital (%)	-16.14	-7.41	- -	- -	- -	- -	- -	-16.47	-41.91	-39.46	-23.16	-0.94	-0.85	-0.76	-0.64
Total Debt/Total Assets (%)	163.34	60.57	- -	- -	- -	- -	- -	34.62	77.18	136.9	116.65	9.68	18.48	18.48	16.19
Net Debt to Equity	-129.89	-142.05	-99.07	-106.14	-102.61	-103.17	-97.87	-90.47	367.4	-126.78	-131.77	-108.32	-14.77	-18.48	-27.84
Net Debt/Capital (%)	-15.14	-4.07	40.27	27.62	22.76	29.82	24.75	14.53	-5.2	-22.13	-13.43	3.93	0.46	0.53	0.78
EBITDA	-5	-16	-26	-54	-85	-90	-77	-130	-150	-151	-79	12	-8	-4	-3
EBITDA-CapEx	-5	-16	-26	-55	-86	-91	-78	-151	-174	-153	-81	12	-8	-4	-3
Operating Income (Loss)	-5	-16	-26	-54	-85	-90	-78	-130	-151	-156	-80	11	-9	-5	-4

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.04	0.43	7.41	4.8	6.07	8.78	9.54	3.93	3.03	1.36	0.26	0.81	0.63	0.98	1.56
Current Ratio	0.39	1.28	8.12	5.26	6.63	9.3	10.48	4.55	3.93	2.17	0.47	1.18	1.72	2.37	3.02
Quick Ratio	0.05	0.63	7.67	5.03	6.35	9.08	9.87	4.2	3.49	1.91	0.4	0.81	1.08	1.67	2.3
CFO/Avg Current Liab	-2.94	-3.76	-3.8	-5.06	-7.4	-5.39	-5.38	-3.93	-3.52	-2.84	-0.91	0.06	-0.86	0.19	0.49
Common Equity/Total Assets	-1,175.36	-877.74	-129.62	-227.82	-297.91	-217.24	-269.81	-244.85	-261.35	-483.81	-620.37	-1,038.44	-2,192.69	-2,451.73	-2,529.16
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	75.24	2,214.73	- -	- -	20.97	22.3	20.25	19.06
Long-Term Debt/Capital (%)	- -	-7.41	- -	- -	- -	- -	- -	-16.47	-41.6	-39.11	-0.94	-0.79	-0.69	-0.59	-0.54
Long-Term Debt/Total Assets (%)	- -	60.57	- -	- -	- -	- -	- -	34.62	76.61	135.66	4.76	8.15	15.08	14.28	13.6
Total Debt/Equity (%)	-137.28	-250.44	- -	- -	- -	- -	- -	75.24	2,231.05	-200.5	-211.16	24.92	27.33	26.21	22.69
Total Debt/Capital (%)	-16.14	-7.41	- -	- -	- -	- -	- -	-16.47	-41.91	-39.46	-23.16	-0.94	-0.85	-0.76	-0.64
Total Debt/Total Assets (%)	163.34	60.57	- -	- -	- -	- -	- -	34.62	77.18	136.9	116.65	9.68	18.48	18.48	16.19
CFO/Total Liabilities	-157.64	-173.08	-283.79	-425.81	-741.11	-461.48	-571.69	-93.32	-64.54	-52.18	-54.24	16.92	-164.61	10.22	22.76
CFO/CapEx	-131.96	-46.74	-43.28	-73.73	-135.27	-55.7	-92.07	-5.01	-6.94	-99.79	-64.19	26.36	- -	- -	- -
Altman's Z-Score	-12.59	1.84	52.43	32.26	94.14	41.29	51.42	-0.65	-4.19	-10.73	-11.33	-13.82	-35.28	-38.27	-39.32

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	108.39	10.3	7.3	7.82	7.74	5.13	3.8	2.09	2.8	2.29	0.08	3.87	- -	- -	- -
Days Sales Outstanding	3.37	35.43	50.02	46.7	47.15	71.19	96.04	174.49	130.35	159.73	4,862.74	94.37	- -	- -	- -
Inventory Turnover	1.57	1.22	1.47	3.3	4.81	4.74	2.06	1.15	0.84	1.61	0.18	0.37	- -	- -	- -
Days Inventory Outstanding	232.41	298.27	247.62	110.63	75.82	77.02	177.29	316.85	435.82	226.81	2,032.62	995.72	- -	- -	- -
Accounts Payable Turnover	4.32	2.44	0.74	0.9	0.85	0.87	0.53	0.34	0.71	0.6	0.08	-2.25	- -	- -	- -
Accounts Payable Turnover Days	84.4	149.66	493.8	404.31	429.73	418.53	686.39	1,083.76	512.55	606.7	4,326.37	-162.27	- -	- -	- -
Cash Conversion Cycle	151.38	184.03	-196.16	-246.99	-306.76	-270.32	-413.06	-592.42	53.62	-220.16	2,569	1,252.35	- -	- -	- -
Inventory to Cash Days	-229.05	-262.84	-197.6	-63.93	-28.67	-5.83	-81.25	-142.36	-305.47	-67.08	2,830.12	-901.35	- -	- -	- -
Inventories	1	2	1	1	1	1	1	3	12	8	8	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	6	4	3	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	- -	- -	- -	- -
Finished Goods	1	1	1	1	1	1	1	3	5	3	3	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	94	284	665	666	1,796	1,131	1,241	857	596	334	143	50	23	10	- -
- Cash & Cash Equivalents	- -	2	54	51	65	132	127	162	161	80	65	38	4	5	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	4	- -	- -	- -	- -	- -	73	205	249	198	9	8	7	6
Enterprise Value	96	286	610	615	1,731	1,000	1,114	769	641	502	276	21	27	12	-1
Total Capital	-15	-48	-80	-135	-220	-310	-386	-446	-490	-630	-854	-931	-942	-945	-946
Total Debt/Capital (%)	-16.14	-7.41	- -	- -	- -	- -	- -	-16.47	-41.91	-39.46	-23.16	-0.94	-0.85	-0.76	-0.64
Total Debt / EV	0.02	0.01	- -	- -	- -	- -	- -	0.1	0.32	0.5	0.72	0.41	0.29	0.6	-4.4
EV/Sales	45.97	74.93	69.56	40.92	85.94	51.66	66.41	47.77	12.9	7.73	107.29	0.3	20.87	6.83	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.78	25.48	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.98	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.26	- -	10.29	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.18	- -	10.29	- -
Diluted Market Cap	94	284	665	666	1,796	1,131	1,241	857	596	334	143	52	23	10	- -
Diluted Enterprise Value	96	286	610	615	1,731	1,000	1,114	769	641	502	276	23	27	12	-1
EV per Share	76.78	156.11	239.26	205.35	499.82	254.96	271.07	170.9	130.02	91	34.68	2.34	2.6	1.04	- -
TTM Sales	2	4	9	15	20	19	17	16	50	65	3	70	1	2	3
TTM EBITDA	-5	-16	-26	-54	-85	-90	-77	-130	-150	-151	-79	12	-8	-4	-3
TTM Operating Income	-5	-16	-26	-54	-85	-90	-78	-130	-151	-156	-80	11	-9	-5	-4
TTM Cash Flow to Firm	-5	-11	-18	-45	-79	-69	-76	-102	-149	-133	-120	9	-23	1	2
TTM Free Cash Flow to Firm	-5	-11	-18	-45	-78	-68	-75	-81	-125	-132	-118	10	-23	1	2

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-19.03	-22.79	-32.76	-14.84	-22.89	-16.66	-16.48	-10.03	-4.2	-2.11	-1.02	5.39	-1.02	8.48	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.98	- -	- -	- -
Enterprise Value	96	286	610	615	1,731	1,000	1,114	769	641	502	276	21	27	12	-1
Low Price	25.5	62.5	82.5	171	200	219.5	175	175.5	91	42.5	17.5	1.99	1.95	0.7	0.72
EV/Sales	45.97	74.93	69.56	40.92	85.94	51.66	66.41	47.77	12.9	7.73	107.29	0.3	20.87	6.83	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.78	25.48	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.45	- -	- -	- -
Price/Earnings Average	-13.28	-7	-13.93	-13.76	-13.49	-15.6	-15.05	-9.64	-5.07	-2.29	-2.45	0.79	-3.78	-9.86	- -
Price/Earnings High	-48.41	-9.39	-24.69	-24.88	-22.92	-22.19	-22.18	-13	-8.52	-4.4	-6.35	2.46	-6.59	-14.54	- -
Price/Earnings Low	-2.47	-3.26	-7.41	-9.44	-8.14	-9.58	-9.35	-5.96	-2.55	-1.28	-0.81	0.16	-1.98	-3.7	- -
Price/Book Value	-5.55	-5.46	-8.27	-4.95	-8.18	-3.66	-3.21	-1.65	-0.86	-0.38	-0.14	-0.05	-0.02	-0.01	- -
Price/Book Value Average	-10.14	-4.73	-4.93	-5.54	-5.22	-4.53	-3	-2.46	-1.28	-0.48	-0.4	-0.09	-0.04	-0.02	- -
Price/Book Value High	-36.97	-6.34	-8.73	-10.02	-8.88	-6.44	-4.41	-3.32	-2.16	-0.92	-1.04	-0.29	-0.07	-0.03	- -
Price/Book Value Low	-1.89	-2.2	-2.62	-3.8	-3.15	-2.78	-1.86	-1.52	-0.64	-0.27	-0.13	-0.02	-0.02	-0.01	- -
Price/Tangible Book Value	-52.86	-169.82	12.3	14.13	29.23	9.05	9.79	11.68	-16.9	-2.02	-1.42	1.79	1.01	0.43	- -
Price/Tangible Book Value Average	-96.67	-147.02	7.33	15.81	18.68	11.21	9.13	17.42	-25.3	-2.54	-4.19	3.13	1.68	0.93	- -
Price/Tangible Book Value High	-352.39	-197.21	12.99	28.61	31.73	15.94	13.45	23.47	-42.53	-4.88	-10.86	9.76	2.92	1.38	- -
Price/Tangible Book Value Low	-17.97	-68.48	3.9	10.86	11.27	6.88	5.67	10.76	-12.71	-1.42	-1.38	0.64	0.88	0.35	- -
Price/Sales	44.91	74.4	75.74	44.34	89.15	58.45	73.99	53.25	12.01	5.14	55.68	0.72	18.04	5.63	- -
Price/Sales Average	82.13	64.41	45.13	49.64	56.97	72.43	69.02	79.44	17.98	6.48	163.9	1.26	29.87	12.21	- -
Price/Sales High	299.38	86.4	79.95	89.78	96.81	103.03	101.67	107.07	30.22	12.45	425.37	3.94	52.04	18.01	- -
Price/Sales Low	15.27	30	23.99	34.08	34.39	44.47	42.87	49.06	9.03	3.61	54.14	0.26	15.64	4.58	- -
Price/Cash Flow	-18.88	-22.3	-32	-14.64	-22.72	-16.36	-16.3	-8.03	-3.6	-2.09	-1	5.39	-1.02	8.48	- -
Price/Cash Flow Average	-34.53	-19.31	-19.07	-16.38	-14.52	-20.28	-15.21	-11.97	-5.39	-2.64	-2.96	9.44	-1.68	18.38	- -
Price/Cash Flow High	-125.87	-25.9	-33.78	-29.64	-24.67	-28.84	-22.4	-16.14	-9.05	-5.06	-7.67	29.42	-2.94	27.11	- -
Price/Cash Flow Low	-6.42	-8.99	-10.14	-11.25	-8.76	-12.45	-9.45	-7.39	-2.71	-1.47	-0.98	1.92	-0.88	6.9	- -
Price/Free Cash Flow Average	-34.8	-19.73	-19.52	-16.61	-14.63	-20.65	-15.37	-14.96	-6.29	-2.66	-3	9.43	-1.68	18.38	- -
Price/Free Cash Flow High	-126.83	-26.46	-34.58	-30.04	-24.85	-29.37	-22.65	-20.16	-10.58	-5.12	-7.79	29.41	-2.94	27.11	- -
Price/Free Cash Flow Low	-6.47	-9.19	-10.37	-11.4	-8.83	-12.68	-9.55	-9.24	-3.16	-1.48	-0.99	1.92	-0.88	6.9	- -
EV/Sales Average	83.2	64.94	38.95	46.22	53.76	65.63	61.45	73.96	18.88	9.07	215.51	0.84	32.69	13.41	- -
EV/Sales High	300.45	86.93	73.78	86.36	93.59	96.23	94.1	101.59	31.11	15.04	476.98	3.52	54.87	19.21	- -
EV/Sales Low	16.33	30.53	17.81	30.66	31.18	37.68	35.3	43.58	9.93	6.2	105.75	- -	18.46	5.79	- -
EV/EBITDA Average	-32.34	-15.41	-13.27	-12.86	-12.72	-14.1	-13.32	-9.16	-6.26	-3.88	-7.03	4.97	-5.6	-6.63	0.46
EV/EBITDA High	-116.78	-20.63	-25.14	-24.04	-22.15	-20.67	-20.39	-12.59	-10.31	-6.44	-15.57	20.74	-9.4	-9.49	0.46
EV/EBITDA Low	-6.35	-7.24	-6.07	-8.53	-7.38	-8.09	-7.65	-5.4	-3.29	-2.66	-3.45	-0.96	-3.16	-2.86	0.46
EV/EBIT Average	-32.01	-15.35	-13.24	-12.85	-12.71	-14.08	-13.28	-9.14	-6.2	-3.78	-6.97	5.53	-4.99	-4.88	0.33
EV/EBIT High	-115.6	-20.55	-25.09	-24.01	-22.13	-20.64	-20.34	-12.56	-10.22	-6.27	-15.42	23.07	-8.38	-6.98	0.33
EV/EBIT Low	-6.28	-7.22	-6.06	-8.53	-7.37	-8.08	-7.63	-5.39	-3.26	-2.59	-3.42	-1.06	-2.82	-2.1	0.33
Last Price	75	155	260.5	222.5	518.5	288.5	302	190.5	121	60.5	18	5.59	2.25	0.86	1.63
High Price	500	180	275	450.5	563	508.5	415	383	304.5	146.5	137.5	30.5	6.49	2.75	2.44
Enterprise Value Average	174	248	342	694	1,083	1,270	1,031	1,191	937	588	554	59	43	24	-1
Enterprise Value High	627	332	647	1,298	1,885	1,863	1,579	1,635	1,545	976	1,227	246	71	34	-1
Enterprise Value Low	34	117	156	461	628	729	592	702	493	402	272	-11	24	10	-1

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	2	2	3	3	4	4	4	5	5	6	9	9	12	12	12
Diluted Weighted Avg Shares	1	2	3	3	3	4	4	5	5	6	8	9	10	12	- -
Basic Weighted Avg Shares	1	2	3	3	3	4	4	5	5	6	8	9	10	12	- -
Revenue per Share	1.67	2.08	3.44	5.02	5.82	4.94	4.08	3.58	10.08	11.77	0.32	7.75	0.12	0.15	- -
EBITDA per Share	-4.3	-8.78	-10.09	-18.03	-24.58	-22.98	-18.83	-28.87	-30.41	-27.48	-9.9	1.31	-0.73	-0.31	- -
Operating Income per Share	-4.34	-8.81	-10.12	-18.05	-24.6	-23.01	-18.89	-28.93	-30.69	-28.21	-10	1.18	-0.82	-0.42	- -
Basic EPS, GAAP	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-21.66	12.41	-0.98	-0.19	- -
Basic EPS from Cont Ops	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-9.96	0.12	-0.74	-0.2	- -
Diluted EPS, GAAP	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-21.66	11.96	-0.98	-0.19	- -
Diluted EPS from Cont Ops	-10.33	-19.16	-11.14	-18.11	-24.56	-22.92	-18.71	-29.47	-35.75	-33.29	-9.96	0.11	-0.74	-0.2	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.97	-6.95	-8.14	-15.2	-22.82	-17.63	-18.53	-23.73	-33.63	-28.93	-17.93	1.04	-2.21	0.1	- -
Free Cash Flow per Basic Share	-4	-7.1	-8.33	-15.41	-22.99	-17.95	-18.73	-28.47	-38.48	-29.22	-18.21	1	-2.21	0.1	- -
Cash & Equivalents per Share	0.1	0.85	21.24	17.15	18.68	33.54	30.93	35.91	32.64	14.6	8.15	4.22	0.41	0.44	- -
Book Value per Share	-13.52	-28.38	-31.51	-44.95	-63.42	-78.92	-94.01	-115.33	-141.09	-159.38	-132.08	-104.05	-90.95	-82.54	- -
Tangible Book Value per Share	-1.42	-0.91	21.18	15.75	17.74	31.89	30.85	16.32	-7.16	-30.01	-12.66	3.12	2.22	2	- -

TherapeuticsMD, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)